Management
The CardiNor management team have extensive experience from the IVD industry, covering every aspect of a company’s life cycle, from start-up phase to exit. This includes high-level business negotiations, licensing agreements, scientific marketing, and successful trade sales.
Kristin Sandereid
CEO
Kristin Sandereid has more than 20 years’ experience from business development within MedTech and technology transfers. Most recently from Removaid AS, a company developing and selling medical devices for removal of subdermal implants.
Sandereid holds a degree in molecular biology. She has extensive experience from international sales of technology, building business models and collecting funding for start-up companies.
Dag Christiansen
COO
Dag Christiansen, one of the founders of CardiNor and previous CEO, has more than 30 years of experience in the diagnostic and pharmaceutical industries including various management positions at DiaGenic, Axis-Shield and Dyno Particles.
He has a very broad and strong knowledge in the field of cardiovascular biomarkers from the technical, regulatory and business development side.
Christiansen holds an MSc in Biochemistry and a BSc in Economics and Business Administration.
Arne Ludvig Faaren
Senior Scientist
Arne Ludvig Faaren has more than 25 years of experience in assay development and commercialisation of IVD products from Axis-Shield and Alere.
He also has a long track record of technology transfer of several important biomarker assays on to proprietary IVD platforms, including PoC instruments.
Faaren holds an MSc in biochemistry from the University of Oslo